Thus, our results in the present study suggest that the increased level of HIF1α synthesis is able to enhance AD pathogenesis by inducing the expression of cell cycle regulatory proteins and allow us to speculate that HIF1α inhibition provides an alternative approach for therapeutic targeting. The gene discussed is HIF1A; the disease is Alzheimer disease.